XBiotech Inc.
XBIT
$2.20
$0.000.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -6.73M | -5.51M | -26.89M | -6.01M | -1.76M |
| Total Depreciation and Amortization | 302.00K | 332.00K | 378.00K | 427.00K | 439.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.58M | 1.30M | -1.00M | 1.23M | -2.97M |
| Change in Net Operating Assets | 327.00K | -5.10M | 4.57M | 96.00K | -1.70M |
| Cash from Operations | -4.52M | -8.97M | -22.95M | -4.26M | -5.99M |
| Capital Expenditure | -- | -- | -34.00K | -110.00K | -51.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -4.00K | 9.00K | -- | -- | -- |
| Cash from Investing | -4.00K | 9.00K | -34.00K | -110.00K | -51.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 0.00 | 0.00 | 0.00 |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | 0.00 | 0.00 | 0.00 |
| Foreign Exchange rate Adjustments | -1.41M | -1.13M | 1.17M | -1.20M | 3.08M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.93M | -10.09M | -21.82M | -5.57M | -2.96M |